TABLE 4

Clinical data for the extended morbidly obese group (n = 579), the type 2 diabetic and normoglycemic sub-groups (n = 579), and the control group (n = 225)

Extended morbidly obese group
Control group
Morbidly obese normoglycemic and type 2 diabeticMorbidly obese type 2 diabetic subgroup 1Morbidly obese normoglycemic subgroup 2Nonobese normoglycemic
n579360219225
Age at diagnosis (years)47.3 ± 12.749.7 ± 11.643.3 ± 13.359.8 ± 11.9
BMI (kg/m2)46.8 ± 7.847.0 ± 8.246.4 ± 7.022.7 ± 2.3
Max BMI (kg/m2)49.8 ± 8.750.0 ± 9.149.3 ± 7.9
Z score of BMI*6.4 ± 2.56.3 ± 2.56.6 ± 2.4−0.51 ± 0.54
Sex ratio (F/M)439/140250/110189/30133/92
  • Data are means ± SD.

  • *

    * Z score of the BMI was defined as the variation of the BMI when compared with age- and sex-matched French reference population.